Cat. No. 5801
Chemical Name: 5-(Dimethyl-1,2-oxazol-4-yl)-1-[2-(
Biological ActivitySelective CBP/p300 bromodomain inhibitor (IC50 values are 125 and 363 nM, respectively). Exhibits >100-fold selectivity for CBP over BRD4. Also exhibits selectivity over a panel of other bromodomains. Reduces LPS-induced IL-1β, IL-6 and IFN-β expression in macrophages in vitro. Also downregulates RGS4 expression in primary cortical neurons in vitro.
Licensing InformationSold for research purposes under agreement from Pfizer Inc.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Chekler et al (2015) Transcriptional profiling of a selective CREB binding protein bromodomain inhibitor highlights therapeutic opportunities. Chem.Biol. 22 1588. PMID: 26670081.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses PF CBP1 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: PF CBP1, supplier, PFCBP1, selective, CBP, CREBBP, EP300, bromodomains, inhibitors, inhibits, Tocris Bioscience, Bromodomain Inhibitor products
Find multiple products by catalog number
New Products in this Area
Potent and selective inhibitor of cat eye syndrome chromosome region, candidate 2 (CECR2)NI 42
High affinity BRPF inhibitorBI 9564
Potent and selective BRD9 and BRD7 inhibitor; orally activeISOX DUAL
Dual BRD4 and CBP/p300 bromodomain inhibitorISOX INACT
Negative control for PF-CBP1 (Cat. No. 5801)
October 30 - November 3, 2016
Boston, MA, USA